The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Current Market Size and Growth

• 2023 Market Size: $5.91 billion
• 2024 Market Size: $6.79 billion
• CAGR (2023-2024): 14.9%

The primary cell culture market has experienced significant growth in recent years, driven by increasing demand for monoclonal antibodies, novel therapeutics, personalized medicine, and cell therapy research.

Future Market Projections

• 2028 Market Size: $11.89 billion
• CAGR (2024-2028): 15%

The market is expected to continue its rapid growth, fueled by the rising incidence of cancer, expanding pharmaceutical and biotechnology industries, growing demand for personalized medicine, and applications in 3D cell culture models. Major trends include technological advancements, product innovation, partnerships, and increased research and development.

Rising Prevalence of Chronic Diseases

• Impact: Chronic diseases significantly drive market growth.
• Factors: Lifestyle changes, environmental influences, physical inactivity, dietary shifts, demographic changes.
• Statistics: Chronic disease prevalence to nearly double from 71.522 million in 2020 to 142.66 million by 2050 (National Center for Biotechnology Information).

Primary cell cultures play a crucial role in understanding and developing treatment strategies for chronic diseases, improving patient outcomes.

View More On The Primary Cell Culture Market Report 2024 – https://www.thebusinessresearchcompany.com/report/primary-cell-culture-global-market-report

Key Market Players

• Major Companies: Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec and CO.KG, STEMCELL Technologies Inc., Cyagen Biosciences Inc., Hi Media Laboratories Pvt. Ltd., PromoCell GmbH, AllCells LLC, BPS Bioscience Inc., MatTek Ltd., Axol Bioscience Ltd., Lifeline Cell Technology Corp., Neuromics Inc., Cell Biologics Inc., ZenBio Inc., Epithelix Sàrl, ReachBio LLC, AcceGen Biotechnology, Biopredic International, ixCells Biotechnologies.

These companies are instrumental in driving the primary cell culture market through innovation and strategic initiatives.

Development of Cost-Effective Cell Banks

• Innovation: Development of cell banks for cultivated meat research.
• Benefits: High-quality animal primary cells, 90% cheaper, no licensing restrictions.
• Example: In June 2023, Extracellular launched low-cost, license-free cell banks for cow, pig, and lamb tissues to support cultivated meat research.

This initiative aims to advance sustainable and ethical meat production technologies, promoting the growth of the cultivated meat industry.

AnaBios Corporation’s Strategic Acquisition

• Acquisition: AnaBios Corporation acquired Cell Systems in April 2023.
• Purpose: Expand human tissue and cell portfolio for drug discovery.
• Benefits: Provides researchers with biologically relevant tools to expedite drug discovery and enhance understanding of cell biology.

This acquisition demonstrates AnaBios’ commitment to expanding its capabilities and supporting advanced drug discovery efforts.

Market Segmentation

• By Product: Primary Cell, Reagents, Supplements, Media
• By Cell Type: Animal Cells, Human Cells
• By Separation and Culture Techniques: Explant Method, Enzymatic Disaggregation, Mechanical Separation, Other Separation
• By Application: Tissue Culture and Tissue Engineering, Vaccine Production, Gene Therapy and Regenerative Medicine, Drug Screening and Toxicity Testing, Cancer Research, Virology, Stem Cell Therapy, Other Applications
• By End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Other End Users

The primary cell culture market’s comprehensive segmentation highlights its diverse applications and the varied needs of different end users.

Regional Insights

• Largest Region (2023): North America
• Fastest-Growing Region (Forecast Period): Asia-Pacific

North America leads the market due to its advanced healthcare infrastructure and strong research capabilities. Asia-Pacific is expected to see the fastest growth, driven by increasing investments in biotechnology and healthcare advancements.

The primary cell culture market is poised for substantial growth, with technological advancements, strategic initiatives, and rising demand for innovative therapies driving its expansion.

Request A Sample Of The Global Primary Cell Culture Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15903&type=smp